|
Biomedical Technology
|
We study the mechanisms of action of antibiotics. One of our major research topics are the studies on inhibitors of protein synthesis. In this field we have been mostly focused on macrolides. Macrolides (of which erythromycin is the most well known example) bind to the large ribosomal subunit and inhibit exit of the newly made nascent peptide chain from the ribosome. We have characterized the length of the nascent peptide chain at which translation starts to be inhibited. In addition, we have observed that the extent of inhibition depends on the sequence of the nascent peptide chain, some nascent peptides being able to remove the drug from the ribosome and thus causing antibiotic resistance. Another line of research is looking at the differentiation of bacterial cultures into cells with different properties. This phenomenon is observed when the bacterial cultures enter into stationary growth phase. It is important to note that these different bacterial cells have different sensitivity to antibiotics, some of them being able to “persist” at high concentrations of the drugs. Our aim is to characterize these different bacterial cells and to elucidate the molecular mechanisms responsible for this differentiation. We are also looking at the evolution of the
translational apparatus. We analyzed the sequence context for initiation of
translation in different organisms. We have also annotated and analyzed the
genes for ribosome associated GTPases in most of the fully sequenced bacterial
genomes. These projects are done in collaboration with Prof Maido Remm from the We several other
longstanding collaborations:
Contact: Nooruse St 1 room 425, Tartu ESTONIA |
||